Kate Therapeutics. is a patient-focused biotechnology company developing next generation AAV-based gene therapies to treat genetically defined muscle and heart disease. We are applying novel technology platforms that directly address the key limitations of current gene therapies, including tissue-specific delivery and gene regulation. These breakthroughs have the potential to improve efficacy and safety of gene therapy and enable the pursuit of a...
Kate Therapeutics. is a patient-focused biotechnology company developing next generation AAV-based gene therapies to treat genetically defined muscle and heart disease. We are applying novel technology platforms that directly address the key limitations of current gene therapies, including tissue-specific delivery and gene regulation. These breakthroughs have the potential to improve efficacy and safety of gene therapy and enable the pursuit of a...
